Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/19/1997 | EP0763129A1 Dna encoding cephamycin biosynthesis late enzymes |
03/19/1997 | EP0763128A1 Method for producing heterologous bispecific antibodies |
03/19/1997 | EP0763127A1 Deblocking the common pathway of aromatic amino acid synthesis |
03/19/1997 | EP0763124A1 Method for introducing nucleic acid in higher eukaryotic cells |
03/19/1997 | EP0763123A1 Safe retroviral vectors, their production and use |
03/19/1997 | EP0763122A1 Retroviral gene therapy vectors and therapeutic methods based thereon |
03/19/1997 | EP0763121A1 Method of cancer treatment by p53 protein control |
03/19/1997 | EP0763120A1 Safe vectors for gene therapy |
03/19/1997 | EP0763119A1 Soluble solids modification using sucrose phosphate synthase encoding sequences |
03/19/1997 | EP0763118A1 Transgenic plants producing trehalose |
03/19/1997 | EP0763117A1 Synthetic leader peptide sequences |
03/19/1997 | EP0763116A1 Recombinant viruses, preparation and use thereof in gene therapy |
03/19/1997 | EP0763115A1 Purified scytalidium laccases and nucleic acids encoding same |
03/19/1997 | EP0763114A2 Hepatitis g virus and molecular cloning thereof |
03/19/1997 | EP0763113A1 Genetic sequences conferring disease resistance in plants and uses therefor |
03/19/1997 | EP0763112A1 Process for preparing doxorubicin |
03/19/1997 | EP0763111A1 Epil/placentine |
03/19/1997 | EP0763110A2 Mn gene and protein |
03/19/1997 | EP0763109A1 Factor interacting with nuclear proteins |
03/19/1997 | EP0763108A1 Dna sequences |
03/19/1997 | EP0763107A1 Pantropic neurotrophic factors |
03/19/1997 | EP0763106A1 Methods and compositions for treatment of restenosis and cancer using ribozymes |
03/19/1997 | EP0763105A1 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof |
03/19/1997 | EP0763104A1 Human dna topoisomerase i-alpha |
03/19/1997 | EP0763103A1 Gene delivery vector using plasmid dna packaged into an adenovirus and a packaging cell line |
03/19/1997 | EP0763101A1 Nucleic acid sequences and expression systems for heparinase ii and heparinase iii derived from flavobacterium heparinum |
03/19/1997 | EP0763060A1 Plant genes for sensitivity to ethylene and pathogens |
03/19/1997 | EP0763059A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
03/19/1997 | EP0763058A1 $i(RPS) GENE FAMILY, PRIMERS, PROBES, AND DETECTION METHODS |
03/19/1997 | EP0763057A1 Method for proliferating and differentiating b cells, and uses thereof |
03/19/1997 | EP0763052A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
03/19/1997 | EP0763050A1 Branched oligonucleotides as pathogen-inhibitory agents |
03/19/1997 | EP0763046A1 Dna encoding gls1 |
03/19/1997 | EP0763045A1 Haemopoietic maturation factor |
03/19/1997 | EP0762894A1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
03/19/1997 | EP0762892A1 Diphtheria toxin vaccines bearing a mutated r domain |
03/19/1997 | EP0762891A1 Immunogenic pharmaceuticals |
03/19/1997 | EP0762889A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation |
03/19/1997 | EP0762885A1 Glial mitogenic factors, their preparation and use |
03/19/1997 | EP0762870A1 Virosome-mediated intracellular delivery of therapeutic agents |
03/19/1997 | EP0745135A4 Method for exponential amplification of nucleic acid by a single unpaired primer |
03/19/1997 | EP0626861B1 Treatment for asthma |
03/19/1997 | EP0596881B1 Expression in non-tumoral human lymphoblastoid lines with an integrative vector |
03/19/1997 | EP0561965A4 Enhancement of musculature in animals |
03/19/1997 | EP0495960B1 Methods for rapid microbial detection |
03/19/1997 | EP0445135B1 Immogenically active fractions of borrelia burgdorferi |
03/19/1997 | CN1145641A DNA mutagenesis by random fragmentation and reassembly |
03/19/1997 | CN1145640A Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
03/19/1997 | CN1145638A Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
03/19/1997 | CN1145637A Alpha-1-antichymotrypsin analogues having elastase inhibitory activity |
03/19/1997 | CN1145636A Vascular endothelial growth factor 2 |
03/19/1997 | CN1145589A Method for antigen-specific immunoregulation by T-Cell alpha chain |
03/19/1997 | CN1145223A Endothelin receptor antagonists |
03/19/1997 | CA2182541A1 Novel, ubiquitous potassium-channel proteins and genes for the same |
03/19/1997 | CA2181880A1 Atp-sensitive potassium-channel proteins and their genes |
03/18/1997 | US5612487 Viricides, antigens and tobacco plants |
03/18/1997 | US5612486 Transgenic animals harboring APP allele having swedish mutation |
03/18/1997 | US5612473 Methods, kits and solutions for preparing sample material for nucleic acid amplification |
03/18/1997 | US5612472 Plant promoter |
03/18/1997 | US5612471 Nematode-induced genes in tomato |
03/18/1997 | US5612470 Nucleic acid encoding the growth hormone releasing hormone receptor |
03/18/1997 | US5612469 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
03/18/1997 | US5612468 Genetic engineering |
03/18/1997 | US5612458 Antibody to PNA/nucleic acid complexes |
03/18/1997 | US5612455 Nuclear factors and binding assay |
03/18/1997 | US5612318 Control of gene expression by ionizing radiation |
03/18/1997 | US5612312 (igf-i)insulin-like growth factor i |
03/18/1997 | US5612216 Nucleotide sequence encoding intercellular adhesion molecule-1 and fragments thereof |
03/18/1997 | US5612215 Stromelysin targeted ribozymes |
03/18/1997 | US5612213 Vector for increased expression of recombinant factor viii |
03/18/1997 | US5612212 Selective inhibition of cell proliferation by vav antisense oligonucleotides |
03/18/1997 | US5612210 Culture of escherichia to produce enzyme |
03/18/1997 | US5612209 Allergies |
03/18/1997 | US5612208 Ascorbate oxidase, gene encoding the same, process for producing the same, and reagent composition using the same |
03/18/1997 | US5612206 Retrovirus infecting primate bone marrow cells and harvesting both non-adherent and adherent cells |
03/18/1997 | US5612205 Producing dna segments |
03/18/1997 | US5612199 Method for producing a polynucleotide for use in single primer amplification |
03/18/1997 | US5612198 Production of insulin-like growth factor-1 in methylotrophic yeast cells |
03/18/1997 | US5612196 Introducing exogenous dna code human serum albumin and culture in medium of ethanol, glycerol, sorbitol, sucrose or esters and recovering |
03/18/1997 | US5612195 Recombinant production of a human interferon (IFN)-gamma antagonist cytokine |
03/18/1997 | US5612194 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
03/18/1997 | US5612193 Genetic engineering |
03/18/1997 | US5612192 DNA base sequence containing regions involved in the production and secretion of a protein, recombinant DNA including the whole or a part of the DNA base sequence, and method of producing proteins by use of the recombinant DNA |
03/18/1997 | US5612191 Plant genes affecting gibberellic acid biosynthesis |
03/18/1997 | US5612190 Screening for vasodilators |
03/18/1997 | US5612184 Plasmids and gene complex from xenorhabdus, receptacles, hermetic sealing containers and detection of bioluminescence |
03/18/1997 | US5612180 Genetic footprinting: insertional mutagenesis and genetic selection |
03/18/1997 | US5612179 Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
03/18/1997 | US5612036 Crosslinked polypeptide vaccine with cysteine groups and carriers |
03/18/1997 | US5612032 Method for diagnosing tumors using mouse monoclonal antibodies |
03/18/1997 | US5612029 Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
03/18/1997 | US5612018 Cyclosporin a for treatment of aids |
03/15/1997 | CA2185517A1 Use of cytohesin-ph peptides for influencing the ability of integrins to adhere |
03/13/1997 | WO1997009451A1 Cloned dna polymerases from thermotoga and mutants thereof |
03/13/1997 | WO1997009449A1 Identification of bases in nucleic acid sequences |
03/13/1997 | WO1997009446A1 Phage display for detergent enzyme activity |
03/13/1997 | WO1997009444A1 Detection of mismatches by resolvase cleavage using a magnetic bead support |
03/13/1997 | WO1997009442A1 Targeted nucleotide sequence delivery and integration system |
03/13/1997 | WO1997009441A2 Improved aav vectors for gene therapy |
03/13/1997 | WO1997009440A1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells |